Rheumatology

“Understanding the drivers of this increased risk in women with gout warrants further investigation in larger datasets," investigators stated.

Dietary counseling could play an important role in the treatment of patients with psoriatic arthritis, contributing to better disease activity control.

“There are no tailored age-specific treatment guidelines, and older adults are less likely to receive aggressive therapy for reasons of polypharmacy and multimorbidity,” investigators stated.

At the outset of the COVID-19 pandemic, there were concerns that patients with rheumatoid arthritis would be more vulnerable due to their condition and its treatment. What impact has the availability of vaccines against COVID-19 had on the vulnerability of patients with rheumatoid arthritis? Test your knowledge with this quiz.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending April 9, 2022.

The survey found 42% of patients with psoriatic disease had never discussed treatment goals with their provider, and less than half of patients with psoriatic arthritis were treated by a rheumatologist.

“These data suggest that vaccine responses are reduced but can be improved by sufficient vaccine/virus exposure,” investigators stated.

Dr. Kenneth J. Warrington led the panel in discussing various topics in rheumatology.

ACR20 response was significantly higher in patients receiving either deucravacitinib 6 mg daily or 12 mg daily when compared with placebo.

Findings provide an advanced look at the potential future role of obinutuzumab in the management of SLE.

There was an adequate response for pediatric patients on biologics to the H1N1 and H3N2 serotypes.

Jeff Peterson, MD, explains the importance of the recent FDA announcement granting priority review of the Supplemental Biologics License Application for concomitant use of pegloticase injection (KRYSTEXXA) plus methotrexate for patients with uncontrolled gout.

Patients with rheumatoid arthritis are at greater risk of cardiovascular disease, but how much do you know about the use of statins in these patients to reduce their risk of cardiovascular morbidity and mortality? Test your knowledge with this quiz.

Patients treated with ixekizumab had higher rates of simultaneous complete skin and nail clearance compared with etanercept, ustekinumab and adalimumab.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending April 2, 2022.

Supported self-management approaches have been shown to benefit patients with chronic health conditions, including gout.

Advice to rheumatologists in terms of staying up to date on newer treatment options entering the market for lupus.

Novel therapies in the pipeline that demonstrate potential advantages when used as treatment for systemic lupus erythematosus and lupus nephritis.

Influenza vaccination rates remain low within patients with rheumatoid arthritis. Investigators urge rheumatologists to encourage vaccination acceptance as a part of routine care.

Patients with psoriatic arthritis and ankylosing spondylitis experienced rapid pain reduction with upadacitinib, regardless of treatment history.

Chronic stressors may play an important role in the development of chronic pain, leading to excess cortisol production and disruption to the body's sympathetic and parasympathetic systems.

“The effects of coffee consumption on SUA levels and gout risk are controversial,” investigators explained. “There have hitherto been no reports based on its effects that consider pleiotropy.”

From the struggle of obtaining insurance approvals to addressing the nationwide shortage of rheumatologists, Dr. Baker Frost talks about her experience treating patients with autoimmune disease.

“[Some] Patients may benefit from switching to a fully human biologic, such as IV-golimumab, to control disease activity/improve drug tolerance," investigators stated.

Patients with rheumatic disease were more likely to have a Pulmonary X-Ray Severity score >9, were more likely to require mechanical ventilation, and had a higher risk of death when compared with controls.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending March 26, 2021.

Expert John Sergent shares insight on his best practices treating patients with autoimmune diseases.

Recommendations for monitoring patients on novel therapies used to manage lupus nephritis and making decisions to taper or stop treatment.

The rationale for treating lupus nephritis with novel therapies such as belimumab and voclosporin.